Replies to post #116 on Abbott Laboratories (ABT)

[DewDiligence]

ABT ‘ReadMeFirst’ updated:

info on Humira, Tofacitinib, and VX-509 from ACR;
FDA approves Xience Prime;
PRGO submits Androgel ANDA;
FDA requests phase-4 “outcomes” trial for TriLipix.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=68938722